Levocetirizine Dihydrochloride
NDC 62135-917, Levocetirizine Dihydrochloride, solution, from Chartwell RX, LLC.
- Product NDC
- 62135-917
- Status
- Listed
- Labeler
- Chartwell RX, LLC
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204599
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62135-917 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LEVOCETIRIZINE DIHYDROCHLORIDE.5 mg/mL
Pharmacologic classes
Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62135-917-38 | 62135091738 | 148 mL in 1 BOTTLE (62135-917-38) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/b56652ad-2cf8-4ed0-bb66-0e832772c792NADAC price for package 62135091738
GET /v1/drugs/nadac/62135091738
Use it
Look up 62135-917 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62135-917 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62135-917. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.